Development Level

Tbio 54 | 10,625
Tchem 9 | 1,890
Tdark 6 | 7,003
Tclin 1 | 602

IMPC Term

preweaning lethality, complete... 5 | 633
embryonic lethality prior to o... 2 | 148
embryonic lethality prior to t... 2 | 187
increased red blood cell distr... 2 | 21
prenatal lethality prior to he... 2 | 64
abnormal coat/ hair morphology 1 | 18
abnormal embryo size 1 | 112
abnormal gait 1 | 51
abnormal heart morphology 1 | 51
abnormal retinal inner nuclear... 1 | 5
abnormal retinal pigmentation 1 | 61
decreased B cell number 1 | 30
decreased caudal vertebrae num... 1 | 49
decreased circulating chloride... 1 | 32
decreased circulating fructosa... 1 | 31
decreased circulating glycerol... 1 | 19
decreased circulating serum al... 1 | 79
decreased grip strength 1 | 123
decreased heart weight 1 | 44
decreased hemoglobin content 1 | 53
decreased prepulse inhibition 1 | 52
decreased rib number 1 | 59
decreased total retina thickne... 1 | 20
embryonic growth retardation 1 | 28
increased circulating creatini... 1 | 29
increased circulating lipase l... 1 | 1
increased circulating sodium l... 1 | 71
increased heart weight 1 | 37
increased mean platelet volume 1 | 19
increased startle reflex 1 | 38
persistence of hyaloid vascula... 1 | 22
preweaning lethality, incomple... 1 | 260

Disease

ovarian cancer 38 | 8,484
osteosarcoma 36 | 7,933
medulloblastoma, large-cell 29 | 6,234
lung cancer 24 | 4,466
Cancer 21 | 2,346
glioblastoma 21 | 5,572
psoriasis 21 | 6,685
atypical teratoid / rhabdoid tumor 18 | 4,369
Multiple myeloma 15 | 1,327
Neurodegenerative disease 15 | 383
malignant mesothelioma 14 | 3,162
intraductal papillary-mucinous adenoma (IPMA) 13 | 2,956
non-small cell lung cancer 13 | 2,798
pediatric high grade glioma 13 | 2,712
astrocytic glioma 12 | 2,241
intraductal papillary-mucinous carcinoma (IPMC) 12 | 2,988
invasive ductal carcinoma 12 | 2,950
lung adenocarcinoma 12 | 2,713
oligodendroglioma 12 | 2,849
Breast cancer 11 | 3,094
Parkinson's disease 11 | 364
Pick disease 11 | 1,893
diabetes mellitus 11 | 1,663
ependymoma 11 | 2,514
group 3 medulloblastoma 11 | 2,254
pancreatic ductal adenocarcinoma liver metastasis 11 | 1,795
primitive neuroectodermal tumor 11 | 3,031
Rheumatoid Arthritis 10 | 1,160
intraductal papillary-mucinous neoplasm (IPMN) 10 | 3,289
pilocytic astrocytoma 10 | 3,086
Alzheimer's disease 9 | 644
Obesity 9 | 616
group 4 medulloblastoma 8 | 1,875
tuberculosis 8 | 1,557
ulcerative colitis 8 | 2,087
colon cancer 7 | 1,475
interstitial cystitis 7 | 2,299
medulloblastoma 7 | 1,524
spina bifida 7 | 1,064
Carcinoma 6 | 2,147
Mammary Neoplasms 6 | 410
atypical teratoid/rhabdoid tumor 6 | 1,095
breast carcinoma 6 | 1,614
lung carcinoma 6 | 2,844
pituitary cancer 6 | 1,972
Anemia 5 | 252
Waldenstrons macroglobulinemia 5 | 765
acute quadriplegic myopathy 5 | 1,157
adult high grade glioma 5 | 2,148
ductal carcinoma in situ 5 | 1,745
hereditary spastic paraplegia 5 | 313
interstitial lung disease 5 | 291
sonic hedgehog group medulloblastoma 5 | 1,482
Liver carcinoma 4 | 217
Neuropathy 4 | 210
Optic atrophy 4 | 43
Parkinson Disease 4 | 102
Parkinsonian Disorders 4 | 23
Prostatic Neoplasms 4 | 471
Vascular disease 4 | 281
adrenocortical carcinoma 4 | 1,427
dermatomyositis 4 | 933
juvenile dermatomyositis 4 | 1,189
progressive supranuclear palsy 4 | 674
Adenocarcinoma 3 | 115
Bowen's Disease 3 | 3
Brain Ischemia 3 | 87
Brain disease 3 | 83
Cerebellar Ataxia 3 | 72
Ceroid lipofuscinosis, neuronal 1, infantile 3 | 10
Chronic progressive external ophthalmoplegia 3 | 18
Diabetes Mellitus, Experimental 3 | 106
Disease Progression 3 | 125
Essential tremor 3 | 30
Intellectual disability 3 | 573
Kidney disease 3 | 396
Metabolic syndrome X 3 | 155
Myocardial Infarction 3 | 126
Nerve Degeneration 3 | 73
Peripheral Neuropathy 3 | 303
Precancerous Conditions 3 | 69
Toxic encephalopathy 3 | 131
aldosterone-producing adenoma 3 | 664
cutaneous lupus erythematosus 3 | 1,056
cystic fibrosis 3 | 1,665
hepatocellular carcinoma 3 | 532
nasopharyngeal carcinoma 3 | 1,056
non primary Sjogren syndrome sicca 3 | 840
pancreatic cancer 3 | 2,300
posterior fossa group B ependymoma 3 | 1,530
primary Sjogren syndrome 3 | 789
subependymal giant cell astrocytoma 3 | 2,287
Diabetes Mellitus, Non-Insulin-Dependent 2 | 157
Down syndrome 2 | 548
Myocardial Ischemia 2 | 169
astrocytoma 2 | 1,493
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | 499
inflammatory breast cancer 2 | 404
pancreatic carcinoma 2 | 567
tuberculosis and treatment for 6 months 2 | 686

Tissue

Blood and immune system 68 | 17,995
Cardiovascular System 68 | 17,958
Digestive Tract 68 | 18,473
Endocrine System 68 | 18,512
Female tissues 68 | 18,647
Liver and Pancreas 68 | 18,136
Male tissues 68 | 17,969
Nervous System 68 | 18,561
Respiratory system 68 | 17,484
Skin and soft tissues 68 | 18,115
Urinary Tract 68 | 18,444

Target Family

Non-IDG 35 | 11,971
Enzyme 24 | 4,146
Transcription Factor 4 | 1,400
Kinase 2 | 634
Transporter 2 | 473
Epigenetic 1 | 242
Ion Channel 1 | 341
Nuclear Receptor 1 | 48

GO Process

mitochondrion organization 70 | 70
transcription, DNA-templated 1,779 | 1,779
regulation of transcription, D... 1,170 | 1,170
signal transduction 969 | 969
positive regulation of transcr... 845 | 845
G-protein coupled receptor sig... 666 | 666
negative regulation of transcr... 620 | 620
apoptotic process 506 | 506
positive regulation of transcr... 504 | 504
negative regulation of transcr... 483 | 483
multicellular organism develop... 456 | 456
positive regulation of cell pr... 451 | 451
cell differentiation 442 | 442
negative regulation of apoptot... 440 | 440
innate immune response 410 | 410
cell adhesion 409 | 409
immune response 398 | 398
negative regulation of cell pr... 379 | 379
inflammatory response 371 | 371
viral process 368 | 368
spermatogenesis 365 | 365
cell proliferation 358 | 358
protein transport 356 | 356
intracellular signal transduct... 355 | 355
cell division 330 | 330
regulation of transcription fr... 324 | 324
protein phosphorylation 320 | 320
response to drug 297 | 297
positive regulation of apoptot... 292 | 292
nervous system development 275 | 275
transcription from RNA polymer... 272 | 272
cell surface receptor signalin... 267 | 267
protein ubiquitination 260 | 260
transport 257 | 257
cell-cell signaling 249 | 249
regulation of immune response 247 | 247
positive regulation of gene ex... 242 | 242
mitotic nuclear division 241 | 241
MAPK cascade 238 | 238
chemical synaptic transmission 238 | 238
mRNA splicing, via spliceosome 219 | 219
angiogenesis 218 | 218
small GTPase mediated signal t... 215 | 215
translation 215 | 215
rRNA processing 209 | 209
intracellular protein transpor... 205 | 205
cellular response to DNA damag... 201 | 201
cell cycle 200 | 200
proteasome-mediated ubiquitin-... 200 | 200
proteolysis 199 | 199
visual perception 198 | 198
DNA repair 196 | 196
extracellular matrix organizat... 193 | 193
regulation of apoptotic proces... 190 | 190
brain development 183 | 183
positive regulation of cell mi... 181 | 181
protein polyubiquitination 181 | 181
in utero embryonic development 178 | 178
Fc-epsilon receptor signaling ... 176 | 176
Wnt signaling pathway 175 | 175
ion transmembrane transport 174 | 174
protein homooligomerization 173 | 173
heart development 170 | 170
positive regulation of ERK1 an... 170 | 170
blood coagulation 169 | 169
cell migration 168 | 168
regulation of cell proliferati... 167 | 167
protein autophosphorylation 166 | 166
response to hypoxia 164 | 164
mRNA processing 162 | 162
negative regulation of canonic... 162 | 162
protein folding 162 | 162
T cell receptor signaling path... 161 | 161
response to lipopolysaccharide 161 | 161
defense response to virus 160 | 160
RNA splicing 158 | 158
aging 158 | 158
positive regulation of I-kappa... 158 | 158
axon guidance 157 | 157
homophilic cell adhesion via p... 155 | 155
sensory perception of smell 155 | 155
ER to Golgi vesicle-mediated t... 151 | 151
interferon-gamma-mediated sign... 150 | 150
protein ubiquitination involve... 150 | 150
transcription initiation from ... 150 | 150
ubiquitin-dependent protein ca... 149 | 149
DNA replication 144 | 144
adaptive immune response 139 | 139
cell cycle arrest 139 | 139
receptor-mediated endocytosis 139 | 139
skeletal system development 136 | 136
regulation of cell shape 135 | 135
regulation of small GTPase med... 134 | 134
G2/M transition of mitotic cel... 133 | 133
oxidation-reduction process 133 | 133
positive regulation of cytosol... 133 | 133
protein stabilization 133 | 133
sensory perception of sound 132 | 132
positive regulation of NF-kapp... 131 | 131
antigen processing and present... 130 | 130
type I interferon signaling pa... 130 | 130

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Host cell factor 1 HCFC1 Tbio Non-IDG -2.50024 341.6 160
Peroxisome proliferator-activated receptor gamma coactivator 1-beta PPARGC1B Tbio Non-IDG -2.61803 420.9 51
Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial CHCHD10 Tbio Non-IDG -1.59923 43.7 53
Clustered mitochondria protein homolog CLUH Tbio Non-IDG -0.53887 4.52 36
Prohibitin PHB Tbio Non-IDG -2.65435 467.0 464
DNA ligase 3 LIG3 Tbio Enzyme -2.71696 505.0 223
Fanconi anemia group G protein FANCG Tbio Non-IDG -2.32299 219.2 272
Cytochrome c CYCS Tbio Non-IDG -3.73952 4771.4 630
Sharpin SHARPIN Tbio Non-IDG -1.20569 20.0 110
Kinesin-like protein KIF28P KIF28P Tdark Non-IDG 0.00000 0